Document Detail


Reduced expression of INT-6/eIF3-p48 in human tumors.
MedLine Citation:
PMID:  11115556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The int-6 gene, originally identified as a common integration site for the mouse mammary tumor virus (MMTV) in mouse mammary tumors, encodes the p48 component of the eukaryotic translation initiation factor-3 (eIF3-p48). Int-6/eIF3-p48 is expressed in all adult tissues which have been tested and early in embryonic development. Int-6/eIF3-p48 has been highly conserved throughout evolution and the deduced amino acid sequence of the human gene product is identical to the mouse protein. Viral insertions at the Int-6/eIF3-p48 locus in mouse mammary tumors result in production of chimeric Int-6/eIF3-p48/MMTV products that may act as dominant negative oncoproteins. Int-6/eIF3-p48 has also been identified as a human protein that binds to the human T-cell leukemia virus type I Tax oncoprotein. The role of Int-6/eIF3-p48 in human carcinogenesis is unknown at the present time. In this study we have examined Int-6/eIF3-p48 gene status and expression in two of the most common forms of cancer in humans, breast and lung tumors. Sixty-two breast carcinomas and 78 non-small cell lung carcinomas (NSCLC) were investigated. LOH at the Int-6/eIF3-p48 locus was observed in 5 (21%) of 24 informative breast tumors and 10 (29%) of 34 informative lung tumors. A reduced expression of Int-6/eIF3-p48 was seen in 23 (37%) of breast cancer samples and 24 (31%) of NSCLC samples. An association between Int-6/eIF3-p48 expression and LOH at the Int-6/eIF3-p48 locus was observed. Int-6/eIF3-p48 expression was not related to commonly used pathological parameters in breast cancer patients, while in NSCLC patients int-6/eIF3-p48 expression was mainly seen in adenocarcinomas (P<0.0001). In conclusion, our data show for the first time a decreased expression of Int-6/eIF3-p48 in a consistent portion of human breast and lung carcinomas, frequently associated with LOH at the Int-6/eIF3-p48 locus. Additional studies on larger series of tumor specimens with long-term follow-up are needed to determine whether Int-6/eIF3-p48 expression may represent a new prognostic or predictive marker.
Authors:
A Marchetti; F Buttitta; S Pellegrini; G Bertacca; R Callahan
Related Documents :
3469456 - Lack of concordance of growth rates of primary and recurrent breast cancer.
17420726 - Downregulation of sef, an inhibitor of receptor tyrosine kinase signaling, is common to...
18563556 - Expression profiling of familial breast cancers demonstrates higher expression of fgfr2...
12475436 - Clinicopathological study on phyllodes tumor of the breast.
11768616 - No effect of thromboxane a2 on the attachment of tumor cell lines mda mb 231, du145, an...
12942546 - Gicerin, an ig-superfamily cell adhesion molecule, promotes the invasive and metastatic...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of oncology     Volume:  18     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2001 Jan 
Date Detail:
Created Date:  2001-01-08     Completed Date:  2001-02-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  175-9     Citation Subset:  IM    
Affiliation:
Department of Oncology and Neurosciences, University Gabriele D'Annunzio, Chieti, Italy. amarchetti@unich.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / diagnosis,  genetics*,  metabolism
Eukaryotic Initiation Factor-3
Female
Humans
Loss of Heterozygosity / genetics
Lung Neoplasms / diagnosis,  genetics*,  metabolism
Male
Prognosis
Proto-Oncogene Proteins / genetics*,  metabolism
RNA, Messenger / metabolism
Tumor Markers, Biological / genetics*,  metabolism
Chemical
Reg. No./Substance:
0/Eukaryotic Initiation Factor-3; 0/Proto-Oncogene Proteins; 0/RNA, Messenger; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased activity and nuclear localisation of inositol lipid signal transduction enzymes in rat hep...
Next Document:  Direct in situ PCR allows rapid and sensitive detection of high risk human papillomavirus in cytolog...